Helix Biopharma Holder Sells 800,000 Shares in Private Sale

Jerzy Wilczewski sold 800,000 common shares at C$1.30 each, reducing his holdings to 7,548,986 shares, or approximately 9.88% from 10.93%. He also holds 1,260 convertible debentures maturing Aug. 2, 2027.